Skip to main content
SpringerLink
Log in

Ciclosporin to tacrolimus switch improves QOL

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Franke GH, Trampenau C, Reimer J, Switch to Tacrolimus for Ciclosporin-Related Side Effects Study Group.Switching from cyclosporine to tacrolimus leads to improved disease-specific quality of life in patients after kidney transplantation. Transplantation Proceedings 38: 1293-1294, No. 5, Jun 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ciclosporin to tacrolimus switch improves QOL. React. Wkly. 1116, 3 (2006). https://doi.org/10.2165/00128415-200611160-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200611160-00007

Keywords

Search

Navigation